Berman Capital Advisors, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Berman Capital Advisors, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$15,000
-6.2%
5660.0%0.00%
-33.3%
Q2 2021$16,000
+6.7%
566
+3.1%
0.00%0.0%
Q1 2021$15,0000.0%549
-2.5%
0.00%
-25.0%
Q4 2020$15,000
+7.1%
5630.0%0.00%0.0%
Q3 2020$14,000
+7.7%
5630.0%0.00%
+33.3%
Q2 2020$13,000
+116.7%
563
+19.5%
0.00%
+50.0%
Q1 2020$6,000
-14.3%
4710.0%0.00%0.0%
Q4 2019$7,000
+16.7%
4710.0%0.00%0.0%
Q3 2019$6,0004710.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,405,039$118,936,0009.40%
Essex Woodlands Management, Inc. 457,085$12,341,0005.10%
Evolutionary Tree Capital Management, LLC 191,868$5,180,0004.98%
Ghost Tree Capital, LLC 390,000$10,530,0002.96%
Antara Capital LP 4,069,400$109,874,0002.90%
RICE HALL JAMES & ASSOCIATES, LLC 896,754$24,212,0001.40%
Jericho Capital Asset Management L.P. 714,000$19,278,0001.22%
Antara Capital LP 1,600,000$43,200,0001.14%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 120,000$3,240,0001.04%
TANG CAPITAL MANAGEMENT LLC 287,500$7,763,0000.95%
View complete list of REVANCE THERAPEUTICS INC shareholders